ANI Pharma Inc (ANIP) 56.41 $ANIP Bio-Techne (TECH) Set

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
ANI Pharma Inc (ANIP) 56.41 $ANIP

Bio-Techne (TECH) Set to Acquire Space Import-Export
Zacks Equity Research - Zacks Investment Research - Wed Jul 06, 8:37AM CDT
Bio-Techne Corporation (TECH) plans to acquire Space Import-Export, an Italy-based distribution company in the Life Sciences space, for an undisclosed sum.
FCSC: 1.24 (+0.04), ANIP: 56.41 (-0.10), CYTR: 2.30 (+0.04), TECH: 114.25 (-0.92)

Merck to Acquire Brazilian Animal Health Company for $400M
Zacks Equity Research - Zacks Investment Research - Tue Jul 05, 10:28AM CDT
Merck (MRK) announced that it will acquire the controlling interest in Vallee S.A., a Brazil-based privately held producer of animal health products.
GWPH: 97.41 (+2.58), ANIP: 56.41 (-0.10), UTHR: 109.92 (-1.24), MRK: 59.60 (+0.25)

Alnylam Stock Up on Favorable Patisiran and Revusiran Data
Zacks Equity Research - Zacks Investment Research - Tue Jul 05, 10:02AM CDT
Alnylam Pharmaceuticals' (ALNY) shares jumped 10.7% after the company reported new data from the ongoing studies on patisiran and revusiran.
ALNY: 63.44 (+1.26), INVA: 11.68 (+0.04), ANIP: 56.41 (-0.10), PFE: 36.23 (+0.11)

XBiotech Xilonix Positive in Phase III Colorectal Cancer Study
Zacks Equity Research - Zacks Investment Research - Mon Jul 04, 8:06AM CDT
XBiotech (XBIT) announced positive results from a phase III study on Xilonix for the treatment of advanced colorectal cancer.
XBIT: 19.17 (+3.39), ANIP: 56.41 (-0.10), PFE: 36.23 (+0.11), BMY: 75.39 (+0.11)

Integra LifeSciences at 52-Week High on Solid Q1 Results
Zacks Equity Research - Zacks Investment Research - Mon Jul 04, 7:32AM CDT
Integra Lifesciences (IART)has a market cap of $2.98 billion and a long-term expected earnings growth rate of 11.86%.
IART: 81.57 (+0.12), INVA: 11.68 (+0.04), FCSC: 1.24 (+0.04), ANIP: 56.41 (-0.10)

5 Top Biotech Performers of 2016
Afrasiab Mian - Zacks Investment Research - Fri Jul 01, 4:19PM CDT
2016 has been a busy year for the Biotech industry. Let's take a look 5 of the strongest year-to-date (YTD) performers.
XBIT: 19.17 (+3.39), ARGS: 6.39 (+0.15), OPXA: 4.43 (+0.17), ANIP: 56.41 (-0.10), RPRX: 1.75 (+0.02)

Arena (ARNA) to Cut 73% Workforce, Shifts Focus to Pipeline
Arpita Dutt - Zacks Investment Research - Fri Jul 01, 8:37AM CDT
Arena (ARNA) is looking to reduce costs through a 73% reduction in its workforce.
ANIP: 56.41 (-0.10), VVUS: 1.17 (-0.01), ARNA: 1.66 (-0.04)

Bristol-Myers, PsiOxus Strike Immuno-Oncology Collaboration
Zacks Equity Research - Zacks Investment Research - Fri Jul 01, 7:28AM CDT
Bristol-Myers (BMY) inked a clinical collaboration agreement with PsiOxus Therapeutics for the evaluation of a combination of Opdivo and enadenotucirev.
ANIP: 56.41 (-0.10), PFE: 36.23 (+0.11), RTRX: 18.51 (-0.14), BMY: 75.39 (+0.11)

Horizon (HZNP) Stock Up on Ravicti Label Expansion Filing
Zacks Equity Research - Zacks Investment Research - Thu Jun 30, 9:11AM CDT
Horizon Pharma (HZNP) announced that it is looking to expand the approved age range for Ravicti for chronic management of urea cycle disorders in the U.S.
ANIP: 56.41 (-0.10), HZNP: 18.91 (+0.20), RTRX: 18.51 (-0.14), BMY: 75.39 (+0.11)

Repligen (RGEN) in Focus: Stock Adds 6.9% in Session
Zacks Equity Research - Zacks Investment Research - Thu Jun 30, 7:45AM CDT
Repligen Corporation (RGEN) was a big mover last session, as the company saw its shares rise nearly 7% on the day.
RGEN: 28.13 (+0.38), ANIP: 56.41 (-0.10)

Esperion (ESPR) Offers Updates on LDL-Lowering Candidate
Zacks Equity Research - Zacks Investment Research - Wed Jun 29, 10:09AM CDT
Esperion (ESPR) announced updates on a clinical development program as well as its regulatory plans for lead candidate, bempedoic acid (ETC-1002).
ESPR: 11.06 (-0.13), ANIP: 56.41 (-0.10), PFE: 36.23 (+0.11), BMY: 75.39 (+0.11)

Endo's Stock Gains on Vasostrict's New Patent Approval
Zacks Equity Research - Zacks Investment Research - Wed Jun 29, 9:38AM CDT
Endo International???s (ENDP) shares jumped 18.3% after the company announced that the U.S. Patent and Trademark Office has issued a new patent for Vasostrict.
ENDP: 17.43 (+0.01), ANIP: 56.41 (-0.10), RTRX: 18.51 (-0.14), BMY: 75.39 (+0.11)

Two Small-Cap Healthcare Stocks That are Cheap Buys Right Now
Zacks Premium Research - Zacks Investment Research - Tue Jun 28, 11:09PM CDT
These small-cap stocks look like a bargain across fundamental valuation metrics. Their upside also has considerable potential.
PMC: 25.79 (+0.15), ANIP: 56.41 (-0.10)

The Medicines Co.'s Carbavance Scores in Phase III Study
Arpita Dutt - Zacks Investment Research - Tue Jun 28, 9:45AM CDT
The Medicines Co. (MDCO) intends to file for FDA approval in early 2017.
MDCO: 35.99 (+1.09), ANIP: 56.41 (-0.10), ARQL: 1.74 (unch), APRI: 0.38 (-0.01)

GW Pharmaceuticals Stock Up on Positive Epidiolex Data
Zacks Equity Research - Zacks Investment Research - Tue Jun 28, 7:33AM CDT
GW Pharmaceuticals (GWPH) announced positive data from the first phase III study on Epidiolex for the treatment of Lennox-Gastaut syndrome.
GWPH: 97.41 (+2.58), ANIP: 56.41 (-0.10), PFE: 36.23 (+0.11), BMY: 75.39 (+0.11)

Zacks.com featured highlights: John Bean Technologies, ANI Pharmaceuticals, Clearwater Paper, Companhia de Saneamento Basico do Estado de Sao Paulo and Unisys
Zacks Equity Research - Zacks Investment Research - Mon Jun 27, 8:30AM CDT
Zacks.com featured highlights: John Bean Technologies, ANI Pharmaceuticals, Clearwater Paper, Companhia de Saneamento Basico do Estado de Sao Paulo and Unisys
JBT: 63.32 (+0.69), CLW: 66.16 (+0.85), ANIP: 56.41 (-0.10), SBS: 9.04 (+0.13), UIS: 7.35 (+0.08)

Sanofi Inks Deal to Swap Business with Boehringer Ingelheim
Zacks Equity Research - Zacks Investment Research - Mon Jun 27, 7:15AM CDT
Sanofi (SNY) signed contracts with Boehringer Ingelheim for the strategic transaction initiated in Dec 2015 regarding an exchange of their businesses.
ANIP: 56.41 (-0.10), PFE: 36.23 (+0.11), RTRX: 18.51 (-0.14), SNY: 41.27 (+0.42)

XBiotech (XBIT) Catches Eye: Stock Adds 5.6% in Session
Zacks Equity Research - Zacks Investment Research - Mon Jun 27, 7:15AM CDT
XBiotech, Inc. (XBIT) shares rose almost 6% in the last trading session.
XBIT: 19.17 (+3.39), ANIP: 56.41 (-0.10)

Genmab/Novartis' Arzerra Gets Unfavorable CHMP Opinion
Zacks Equity Research - Zacks Investment Research - Fri Jun 24, 11:17AM CDT
Genmab (GNMSF) announced that CHMP issued a negative opinion for Arzerra as a maintenance therapy for relapsed chronic lymphatic leukemia.
JNJ: 122.99 (+0.14), ANIP: 56.41 (-0.10), NVS: 82.56 (+0.43)

Gilead's (GILD) HIV Treatment Odefsey Gains Approval in EU
Zacks Equity Research - Zacks Investment Research - Fri Jun 24, 9:08AM CDT
Gilead Sciences' (GILD) once-daily single tablet regimen Odefsey gained EU approval for the treatment of HIV-1 infection in certain patients.
JNJ: 122.99 (+0.14), GILD: 87.13 (+0.58), ANIP: 56.41 (-0.10), RTRX: 18.51 (-0.14)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 264

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 207

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 317

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 175

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 367

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 272

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 414

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
PettiChat’s Digital Pet Twin Has Real Consumer Pull

Updated Category News Views 217

A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 238

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
NatGasHub’s 391% Growth Signals a Real Pipeline Shift

Updated Category News Views 121

Three hundred-plus pipelines is a lot of messy plumbing to tame, and NatGasHub has apparently found a lucrative way to do it. The Houston software company landed at No. 182 on Deloitte’s 2026 Technology Fast 500 after reporting 391% revenue growth from 2022 through 2025. That is a serious number, even in a ranking built to showcase companies sprinting uphill. More...

Continue Reading

Top 5 Most Recently Viewed Articles

Van Horn Automotive Group Partners for Successful Dealership Sale

Updated Category News Views 928

Van Horn Automotive Group Sells Ford and Chevrolet Dealerships Performance Brokerage Services, recognized as a leader in dealership buy-sell transactions, has announced the acquisition of Van Horn Ford and Van Horn Chevrolet from Van Horn Automotive Group, marking an important transition for the dealerships. The new owners, Yelena and Alex Tovstanovsky of Sky Auto Mall,...

Continue Reading
G2 Goldfields Unveils Exciting Drilling Results at OKO

Updated Category News Views 136

G2 Goldfields Expands Mineral Resources at OKO G2 Goldfields Inc. (“G2”) (TSX: GTWO; OTCQX: GUYGF) has some exciting updates to share about its exploration activities at the vast 27,719-acre OKO-AREMU gold project. The company recently provided a significant update on their Mineral Resource Estimate (MRE), which now shows a remarkable total of 922,000 ounces of gold...

Continue Reading
Ecolectro Secures $10.5M Series A Funding for Green Hydrogen

Updated Category News Views 425

Ecolectro's Game-Changing Series A Funding Round Ecolectro has successfully completed a significant funding round, securing $10.5 million to enhance its innovative green hydrogen technology. The funding, led by Toyota Ventures, will enable Ecolectro to further develop its fully integrated and scalable electrolyzers, crucial for producing green hydrogen efficiently and...

Continue Reading
CEI Vision Partners Faces Data Breach Investigation: What to Know

Updated Category News Views 233

CEI Vision Partners Confronts Serious Data Breach Investigation In recent news, CEI Vision Partners, a prominent network of over 300 ophthalmologists and 700 optometrists, finds itself at the center of a significant data breach investigation. The investigation, led by the firm Schubert Jonckheer & Kolbe LLP, aims to uncover the details surrounding unauthorized access to...

Continue Reading
New Ethical AI Tools and Books Revolutionizing College Essays

Updated Category News Views 272

Innovative Solutions for College Essay Writing In light of recent prohibitions against artificial intelligence writing tools at major universities, students are navigating the challenges of crafting their college essays with greater scrutiny. College Essay Advisors has responded to this shift by introducing College EssAI, an innovative ethical AI platform designed to...

Continue Reading